Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells

Colorectal cancer (CRC) is the third most leading cause of morbidity and mortality throughout the world. 5-fluorouracil (5-FU), which is often administrated to disrupt carcinogenesis, was found to elevate blood glucose level among CRC patients. Thus, this study was conducted to evaluate the influenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Meng-Fei, Vellasamy, Shalini, Chua, Kek-Heng, Sabaratnam, Vikineswary, Kuppusamy, Umah Rani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938530/
https://www.ncbi.nlm.nih.gov/pubmed/29743857
http://dx.doi.org/10.17179/excli2018-1011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938530/
https://www.ncbi.nlm.nih.gov/pubmed/29743857
http://dx.doi.org/10.17179/excli2018-1011

Ejemplares similares